Putting Growth Capital to Work in Philadelphia
On average, Safeguard Scientifics evaluates more than a thousand business plans each year—that’s 20 business plans per week. Last year, we chose to partner with…
Posted by
On average, Safeguard Scientifics evaluates more than a thousand business plans each year—that’s 20 business plans per week. Last year, we chose to partner with…
Posted by
The big news today is the Facebook IPO. The company that famously started in a Harvard dorm room set three records at IPO, including the…
Posted by
The convergence of technology and healthcare attracted significant new attention last year, according to research from Dow Jones VentureSource. In 2011, VCs poured $439 million…
Posted by
Readers of this blog are well aware that entrepreneurship is one of our key themes—from our partner company CEO Q&A Series to our book recommendations…
Posted by
The latest report from MoneyTree and the National Venture Capital Association shows that corporate venture capitalists (CVCs) increased investments over the past three years. In…
Posted by
The past two weeks were brought to you by the letters IPO. From Facebook’s well-documented filing to this week’s IPO price cuts, a flurry of…
Posted by
Welcome to the inaugural blog post for Safeguard Scientifics’ Q&A Series, featuring our partner company CEOs! We believe that our blog is a perfect medium…
Posted by
Last year was a strong year for venture capital, according to the MoneyTree report issued by the National Venture Capital Association. Investments grew 22 percent…
Posted by
The J.P. Morgan Healthcare Conference wasn’t the only event on our radar this week. The 2012 International Consumer Electronics Show (CES), the world’s largest consumer…
Posted by